杭州阑尾切除手术模拟人(黑龙江枕骨脊柱和脊神经解剖模型) (今日更新中)

HOUSTON — An Associated Press review of medical records for four detained immigrant women and interviews with lawyers have revealed growing allegations that a gynecologist performed surgeries and other procedures that the women never sought or didn't fully understand.Dr. Mahendra Amin was linked this week to allegations of unwanted hysterectomies performed on immigrant women at Irwin County Detention Center in Georgia.Some procedures could be justified based on problems noted in the medical records, but lawyers and medical experts say the women's lack of consent or knowledge raises severe legal and ethical issues.Amin provided gynecological treatment or performed surgery on eight women dating back to 2017, including one hysterectomy, according to an attorney an immigration and civil rights lawyer working with attorneys to investigate medical treatment at the detention center.The AP's report comes days after a nurse's complaint at the detention center was widely published. Dawn Wooten claimed that many immigrant women were taken to an unidentified doctor she called the "uterus collector" because of how many hysterectomies he performed.In an interview with The Intercept, Amin said he performed "one or two hysterectomies in the past three years." HIs lawyer told the AP that Amin was looking forward to the "facts coming out," and claimed that he would be cleared of wrongdoing.The AP did not find evidence of the "mass hysterectomies" that Wooten alleged. Wooten's complaint prompted outrage from Democrats and an investigation by the Department of Homeland Security's Inspector General.LaSalle Corrections, the private prison company that operates the jail, "strongly" refuted the "allegations and any implications of misconduct." Tony Pham, the acting director of Immigration and Customs Enforcement, said that if the allegations were true, he would make necessary corrections and "continue to prioritize the health, welfare and safety of ICE detainees." 1982

How accurate are the coronavirus tests used in the U.S.?Months into the outbreak, no one really knows how well many of the screening tests work, and experts at top medical centers say it is time to do the studies to find out.When the new virus began spreading, the Food and Drug Administration used its emergency powers to OK scores of quickly devised tests, based mainly on a small number of lab studies showing they could successfully detect the virus.That’s very different from the large patient studies that can take weeks or months, which experts say are needed to provide a true sense of testing accuracy.The FDA’s speedy response came after it was initially criticized for delaying the launch of new tests during a crisis and after the Centers for Disease Control and Prevention stumbled in getting its own test out to states.But with the U.S. outbreak nearly certain to stretch on for months or even years, some experts want the FDA to demand better evidence of the tests’ accuracy so doctors know how many infections might be missed.There have been more than 2 million confirmed coronavirus cases in the U.S. and more than 115,000 deaths, according to data compiled by Johns Hopkins University. Cases in nearly half of U.S. states are rising.In recent weeks, preliminary findings have flagged potential problems with some COVID-19 tests, including one used daily at the White House. Faulty tests could leave many thousands of Americans with the incorrect assumption that they are virus-free, contributing to new flare-ups of the disease as communities reopen.“In the beginning, the FDA was under a lot of pressure to get these tests onto the marketplace,” said Dr. Steven Woloshin of Dartmouth College, who wrote about the issue in the New England Journal of Medicine last week. “But now that there are plenty of tests out there, it’s time for them to raise the bar.”The FDA said in a statement that it has already asked multiple test makers to do follow-up accuracy studies, although it didn’t say for how many of the more than 110 authorized screening tests. The agency also said it is tracking reports of problems. Accuracy has also been an issue with blood tests that look for signs of past infections.No screening test is 100% accurate. So details on accuracy are routinely provided for tests of all types, including seasonal flu, hepatitis, HIV and cancers. For example, rapid flu tests are known to miss 20% or more of all cases, a factor doctors weigh when treating patients who have symptoms but test negative.For now, most COVID-19 tests in the U.S. don’t give data on real-world performance, including how often the tests falsely clear patients of infection or falsely detect the virus. That information is lacking for all but a few of the roughly 80 commercial screening tests available, according to an Associated Press review.The government’s emergency authorization process “requires a lower level of evidence,” the agency said. Makers need only show that a test “may be effective” instead of the usual requirement to demonstrate “safety and effectiveness.” They would have to meet that higher threshold once the U.S. government declares the emergency over.Many of the commercial test makers submitted results from 60 samples, the minimum number required and mostly used lab-produced specimens of the virus. The FDA now recommends the use of nasal swabs or other real samples from people screened for coronavirus.Experts say larger patient studies patients are needed to assess a test’s true performance.Lab testing bears little resemblance to actual — sometimes imperfect — conditions at hospitals, clinics and testing sites noted Dr. Robert Kaplan of Stanford University.“You’re testing people in parking lots, the patients themselves are extremely anxious and often unable to follow instructions,” said Kaplan, a former associate director of the National Institutes of Health.Kaplan and others say those differences could explain why some tests are not performing as expected.Last month, the FDA warned doctors of a potential accuracy problem with Abbott Laboratories’ rapid ID Now test, which delivers results in roughly 15 minutes. The test has been lauded by President Donald Trump and used to screen the president, his staff and visitors to the White House.The FDA alert followed a preliminary report by New York University that found Abbott’s test missed between a third to one-half of infections caught by a rival test in patients screened for the virus.Abbott rejected the findings, saying the researchers did not follow the instructions for using its test. The company pointed to alternate patient studies, including its own, that have found the test successfully detects between 91% and 95% or more of virus cases when compared to other tests.But similar problems with ID NOW’s accuracy have been flagged in preliminary reports by researchers at Stanford University, Loyola University and the Cleveland Clinic.For now, the FDA is requiring Abbott to conduct follow-up studies in several different patient groups.The FDA’s emergency standards “are still high but there is a significant difference in the body of work that what would go into a submission under the normal process,” said Abbott vice president John Hackett. “Our normal process takes years to bring these out.”Requiring bigger studies of all coronavirus tests could provide valuable information, but it could also strain the FDA’s already stretched staff and resources, said Dr. Daniel Schultz, former director of the FDA’s medical device center.Dr. Colin West of the Mayo Clinic worries doctors and patients have put too much confidence in the current crop of tests, when an unknown number of patients with COVID-19 are likely receiving false negative results.Even a modest error rate can have grave consequences during an outbreak like COVID-19. West gives the example of a test that is 95% accurate at detecting the virus and is used on 1 million people. That would still result in 50,000 people being incorrectly told that they don’t have the virus.“The negative test does not mean that I’m off the hook,” West said. “We just need to maintain that level of vigilance until we have a better sense of how good these tests really can be.”___Follow Matthew Perrone on Twitter: @AP_FDAwriter.___Follow AP pandemic coverage at http://apnews.com/VirusOutbreak and https://apnews.com/UnderstandingtheOutbreak.___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. 6604

If you are still out of work, chances are the bonus unemployment check has helped you out. The 0 weekly bonus passed by Congress earlier this year helped millions of Americans who lost their job due to the pandemic. OUT OF TIMEThe benefit is set to expire on July 31, however because of payment schedules, this week will be the final week of the benefit. Congress is not expected to pass a new round of relief by next week although they could offer back-pay should relief legislation eventually pass. WHY IT MIGHT NOT BE EXTENDEDDemocrats have called for extending the benefit or at the very least enhancing current unemployment payouts. Republicans, however, are more skeptical, with some believing the incentive is stopping Americans from returning to work or looking for new work. THIS WEEK IS CRUCIALNegotiations are well underway and this week will be full of developments. That's because Congress is back from their Fourth of July recess. Senator Mitch McConnell and Rep. Kevin McCarthy, both GOP leaders in Congress, met with President Donald Trump at the White House today. On Tuesday, Trump Chief of Staff Mark Meadows and Treasury Secretary Steve Mnuchin will attend meetings on Capitol Hill. President Trump is even rumored to potentially make an in-person appearance on Capitol Hill this week. Everything from expanding small business loans to another stimulus check is expected to be included in the negotiations. 1438

In a World Series dominated by home runs and the long ball, it was the Game 7 pitching performance on Wednesday by the Houston Astros which led the squad to the franchise's first ever World Series title. The Astros defeated the Los Angeles Dodgers 5-1 to win the best-of-seven series by a 4-3 margin. The series was full of twists and turns, with no shortage of excitement. RELATED:?Looking back at whirlwind 2017 World SeriesMembers of the Astros said that the World Series title had extra meaning after a Hurricane Harvey  devastated Houston in late August. The storm forced Houston to play some of its home games in Tampa as the city recovered.  681

House Democrats introduced articles of impeachment Wednesday against President Donald Trump, though they acknowledged their efforts have no chance of success while Republicans control both houses of Congress.Rep. Steve Cohen, D-Tennessee, introduced five articles of impeachment that include obstruction of justice for Trump's decision to fire former FBI Director James Comey, two emoluments clause violations, undermining the independence of the federal judiciary and undermining the freedom of the press. 514

来源：资阳报